| Literature DB >> 26540648 |
Manuel Kaulich1, Steven F Dowdy1.
Abstract
Altering endogenous genes in cells is an integral tool of modern cell biology. The ease-of-use of the CRISPR/Cas9 system to introduce genomic DNA breaks at specific sites in vivo has led to its rapid and wide adoption. In the absence of a DNA template, the lesion is repaired by nonhomologous end joining resolving as internal deletions. However, in the presence of a homologous DNA template, homology-directed repair occurs with variable efficiencies. Recent work has demonstrated that highly efficient gene targeting can be induced by combining CRISPR/Cas9 targeting of genomic loci with recombinant adeno-associated virus (rAAV) to provide a single-stranded homologous DNA template. Here we review the current state of CRISPR/Cas-based gene editing and provide a practical guide to applying the CRISPR/Cas and rAAV system for highly efficient, time- and cost-effective gene targeting.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26540648 PMCID: PMC4657517 DOI: 10.1089/nat.2015.0545
Source DB: PubMed Journal: Nucleic Acid Ther ISSN: 2159-3337 Impact factor: 5.486